Economic implications of the modern treatment paradigm of glioblastoma: an analysis of global cost estimates and their utility for cost assessment

Medicine & Life Sciences

• Glioblastoma 100%
• Economics 78%
• Costs and Cost Analysis 63%
• Therapeutics 16%
• Standard of Care 13%
• Recurrence 7%
• Craniotomy 7%
• Neoplasms 6%
• Brain Neoplasms 6%
• Health Care Costs 6%
• Cost-Benefit Analysis 5%
• Radiation 5%
• Drug Therapy 3%
• Survival 3%
• Health 3%

Social Sciences

• paradigm 66%
• costs 57%
• economics 42%
• treatment modalities 7%
• surgery 6%
• brain 5%
• utilization 4%
• death 4%
• management 2%
• health 2%
• literature 2%